MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures primarily in the United States. It offers MAKOplasty, a restorative surgical solution, which enables orthopedic surgeons to treat patient specific early to mid-stage osteoarthritic knee disease. The company also provides robotic arm interactive orthopedic system consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component that offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling minimally invasive, tissue sparing bone removal and knee implant insertion. In addition, it provides tactile guidance system for use with an inlay knee implant system. Further, the company offers the RESTORIS family of knee implant systems comprising unicompartmental knee implant system and multicompartmental knee implant system that are designed for insertion and cementation in a minimally invasive manner. MAKO Surgical Corp. markets its products through direct sales force, as well as through independent orthopedic product agents and distributors.
The company was incorporated in 2004 and is headquartered in Fort Lauderdale, Florida.
Funding Rounds (3) - $70.1MUpdate
ZMEP is a limited partnership focusing on equity and equity-like investments in emerging medical...
2555 Davie Road
Fort Lauderdale, FL 33317
- 02/14/08 -nasdaq.com